In the days of the Armada, a fleet of warships, the scuttlebutt was the rumor or gossip that would spread throughout the ship. Today, Armada Law Corp presents The Scuttlebutt, a daily summery of news articles that people within the cannabis, hemp and plant medicine industries are chatting about along with links to the full articles.
In today’s news:
#cannabisindustry – Washington – “A Washington state senator has introduced legislation that would ban employers from not hiring someone for using cannabis in the past and put an end to drug tests measuring cannabis metabolites in the body.
Democratic Sen. Karen Keiser introduced Senate Bill 5123 on Friday, saying the legalization of recreational cannabis in Washington “created a disconnect between prospective employees’ legal activities and employers’ hiring practices.”
If passed, the law would make it illegal for an employer to not hire someone based on an employer-required drug test detecting non-psychoactive cannabis metabolites in their hair, blood or other body fluids.”
#cannabisindustry – “Large-scale class actions and other litigation alleging violations of legal obligations regarding payment of wages and related recordkeeping constitute a large percentage of active employment-related litigation and can expose businesses, including individual founders and owners, to exorbitant financial risk. Ensuring accurate timekeeping and compliance with related requirements is key to avoiding such liability.”
#cbdproducts – “A French court has overturned the government’s ban on the sale of CBD flowers, paving the way for a lucrative market that has been held back by strict legislation in recent years.
The French Council of State, which advises the government on legislation and acts as a supreme court for administrative justice, overturned on December 29, 2022, a ban on the sale of CBD flowers in France, stating that a general and absolute ban on the marketing of the product was “disproportionate.”…
France has one of the strictest regulations on cannabis in the EU. However, the government approved in December 2021 the sale of products containing CBD with a THC content of less than 0.3% but simultaneously prohibited the sale of hemp flowers and leaves.”
#cannabisindustry – New York – “Data from New York regulators’ first-ever annual cannabis report shows that less than 1% of those who applied for permits to sell recreational marijuana secured the coveted Conditional Adult-Use Retail Dispensary, or CAURD, licenses.
Of the more than 900 applications that landed on the New York Office of Cannabis Management desk seeking a CAURD license, only 36 were provisionally approved by the New York Cannabis Control Board, according to the inaugural annual report issued by the agency at the start of the year.
The report does not explain exactly why so many were not approved, though it does say that if a robust cannabis market is to exist, it needs efficient registration and a streamlined process.”
#cannabispolitics – “The Ohio Secretary of State has sent an activist-backed recreational cannabis initiative to the state Legislature, leaving lawmakers four months to vote on the proposed legalization bill or send it back to activists to gather a new round of signatures to qualify for the ballot.
A Tuesday letter from Secretary of State Frank LaRose notified House Speaker Jason Stephens and Senate President Matt Huffman that the clock for considering adult-use cannabis is ticking. The proposed law would allow cannabis sales for people 21 years and older and would carry a sales tax rate of 10%.”